Return to home page
Searching: Muskingum library catalog
In response to the COVID-19 outbreak, statewide lending via OhioLINK and SearchOhio has been suspended. OPAL member libraries have closed or are operating at reduced service levels. Please contact your library with specific lending requests or if you need assistance.
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
Title Hepatitis and liver cancer : a national strategy for prevention and control of hepatitis B and C / Heather M. Colvin and Abigail E. Mitchell, editors ; Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practice.
Imprint Washington, DC : National Academies Press, [2010]

Subject Hepatitis B -- United States.
Hepatitis C -- United States.
Liver -- Cancer -- United States.
Hepatitis B -- complications.
Hepatitis B -- prevention & control.
Hepatitis C -- complications.
Hepatitis C -- prevention & control.
Liver Neoplasms -- prevention & control.
Viral Hepatitis Vaccines -- therapeutic use.
United States.
Alt Name Colvin, Heather M.
Mitchell, Abigail E.
Institute of Medicine (U.S.). Committee on the Prevention and Control of Viral Hepatitis Infections.
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice.
Description 1 online resource (xix, 232 pages) : illustrations (some color)
polychrome rdacc
Bibliography Note Includes bibliographical references and index.
Contents Introduction -- Surveillance -- Knowledge and awareness about chronic hepatitis B and hepatitis C -- Immunization -- Viral hepatitis services.
Summary "The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have chronic hepatitis C. People most at risk for hepatitis B and C often are the least likely to have access to medical services. Reducing the rates of illness and death associated with these diseases will require greater awareness and knowledge among health care workers, improved identification of at-risk people, and improved access to medical care. Hepatitis B is a vaccine-preventable disease. Although federal public health officials recommend that all newborns, children, and at-risk adults receive the vaccine, about 46,000 new acute cases of the HBV infection emerge each year, including 1,000 in infants who acquire the infection during birth from their HBV-positive mothers. Unfortunately, there is no vaccine for hepatitis C, which is transmitted by direct exposure to infectious blood. Hepatitis and Liver Cancer identifies missed opportunities related to the prevention and control of HBV and HCV infections. The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis. It identifies priorities for research, policy, and action geared toward federal, state, and local public health officials, stakeholder, and advocacy groups and professional organizations."--Publisher's description.
Note Print version record.
ISBN 9780309146296 (electronic bk.)
0309146291 (electronic bk.)
0309146283 (hardcover)
9780309146289 (hardcover)
OCLC # 648761504
Additional Format Print version: Hepatitis and liver cancer. Washington, DC : National Academies Press, ©2010 9780309146289 (DLC) 2010003194 (OCoLC)502393600

If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team